Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Heregulin, a new regulator of telomere length in human cells

Journal Article · · Oncotarget
 [1];  [2];  [3];  [4]
  1. ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism & Cancer Group, Catalan Institute of Oncology (ICO), Girona, Spain; Girona Biomedical Research Institute (IDIBGI), Girona, Spain; DOE/OSTI
  2. Laboratory of Hematology Service, Institut d'Investigació Biomèdica Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
  3. Lawrence Berkeley National Laboratory, Life Sciences Division, Berkeley, CA, USA; Buck Institute for Research on Aging, Novato, CA, USA
  4. Mayo Clinic, Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Rochester, MN, USA; Mayo Clinic Cancer Center, Rochester, MN, USA
The growth factor heregulin (HRG) promotes breast cancer (BC) tumorigenesis and metastasis and differentially modulates BC cell responses to DNA-damaging agents via its dual extracellular and nuclear localization. Given the central role of telomere dysfunction to drive carcinogenesis and to alter the chemotherapeutic profile of transformed cells, we hypothesized that an unanticipated nuclear function of HRG might be to regulate telomere length. Engineered overexpression of the HRGβ2 isoform in non-aggressive, HRG-negative MCF-7 BC cells resulted in a significant shortening of telomeres (up to 1.3 kb) as measured by Southern blotting of telomere terminal restriction fragments. Conversely, antisense-mediated suppression of HRGβ2 in highly aggressive, HRG-overexpressing MDA-MB-231 and Hs578T cells increased telomere length up to 3.0 kb. HRGβ2 overexpression promoted a marked upregulation of telomere-binding protein 2 (TRF2) protein expression, whereas its knockdown profoundly decreased TRF2 expression. Double staining of endogenous HRGβ2 with telomere-specific peptide nucleic acid probe/fluorescence in situ hybridization (PNA/FISH) revealed the partial localization of HRG at the chromosome ends. Moreover, a predominantly nucleoplasmic staining pattern of endogenous HRGβ2 appeared to co-localize with TRF2 and, concomitantly with RAP1, a telomere regulator that specifically interacts with TRF2. Small interfering RNA-mediated knockdown of HRG decreased the expression of TRF2 and RAP1, decreased their presence at chromosome ends, and coincidentally resulted in the formation of longer telomeres. This study uncovers a new function for HRGβ2 in controlling telomere length, in part due to its ability to regulate and interact with the telomere-associated proteins TRF2 and RAP1.
Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
USDOE
Grant/Contract Number:
AC03-76SF00098
OSTI ID:
1627987
Journal Information:
Oncotarget, Journal Name: Oncotarget Journal Issue: 37 Vol. 6; ISSN 1949-2553
Publisher:
Impact JournalsCopyright Statement
Country of Publication:
United States
Language:
English

References (75)

Role of the telomeric DNA-binding protein TRF2 in the stability of human chromosome ends journal December 1998
The significance ofheregulin in breast cancer tumor progression and drug resistance journal February 1996
Telomere length mediates the effects of telomerase on the cellular response to genotoxic stress journal August 2004
Up-Regulation of Telomere-Binding Proteins, TRF1, TRF2, and TIN2 Is Related to Telomere Shortening during Human Multistep Hepatocarcinogenesis journal January 2005
Telomere Shortening Occurs in Subsets of Normal Breast Epithelium as well as in Situ and Invasive Carcinoma journal March 2004
Telomeres Do D-Loop–T-Loop journal May 1999
TRF2 Protects Human Telomeres from End-to-End Fusions journal February 1998
Switching and Signaling at the Telomere journal September 2001
Tankyrase promotes telomere elongation in human cells journal October 2000
Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma journal March 1999
Telomere Shortening Occurs Early During Breast Tumorigenesis: A Cause of Chromosome Destabilization Underlying Malignant Transformation? journal July 2004
Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis journal September 2000
Human telomeres contain two distinct Myb–related proteins, TRF1 and TRF2 journal October 1997
XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer journal September 2005
Telomeres and human disease: ageing, cancer and beyond journal August 2005
Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer journal February 2003
A deletion mutant of heregulin increases the sensitivity of breast cancer cells to chemotherapy without promoting tumorigenicity journal May 2003
Accumulation and altered localization of telomere-associated protein TRF2 in immortally transformed and tumor-derived human breast cells journal February 2005
Telomere dysfunction alters the chemotherapeutic profile of transformed cells journal March 2001
Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses. journal March 1992
Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction journal September 2002
Massive Telomere Loss Is an Early Event of DNA Damage-induced Apoptosis journal January 2003
The Human Rap1 Protein Complex and Modulation of Telomere Length journal April 2004
TIN2 Mediates Functions of TRF2 at Human Telomeres journal October 2004
Telosome, a Mammalian Telomere-associated Complex Formed by Multiple Telomeric Proteins journal September 2004
Short Telomeres Result in Organismal Hypersensitivity to Ionizing Radiation in Mammals journal December 2000
They don't care journal January 2001
Telomere-bound TRF1 and TRF2 stall the replication fork at telomeric repeats journal March 2004
Shelterin: the protein complex that shapes and safeguards human telomeres journal September 2005
Senescence Induced by Altered Telomere State, Not Telomere Loss journal March 2002
Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185 erb B2 journal September 1990
Identification of Heregulin, a Specific Activator of p185 erbB2 journal May 1992
Tankyrase, a Poly(ADP-Ribose) Polymerase at Human Telomeres journal November 1998
Control of Human Telomere Length by TRF1 and TRF2 journal March 2000
The role of ErbB-2 tyrosine kinase receptor in cellular intrinsic chemoresistance: mechanisms and implications journal August 1997
Regulation of Telomerase by Telomeric Proteins journal June 2004
Role of Human Ku86 in Telomere Length Maintenance and Telomere Capping journal October 2004
Telomeres: what's new at your end? journal July 2005
Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage journal March 2005
Role of the TRF2 Telomeric Protein in Cancer and Aging journal March 2006
Role of the telomeric DNA-binding protein TRF2 in the stability of human chromosome ends journal December 1998
The significance ofheregulin in breast cancer tumor progression and drug resistance journal February 1996
Up-Regulation of Telomere-Binding Proteins, TRF1, TRF2, and TIN2 Is Related to Telomere Shortening during Human Multistep Hepatocarcinogenesis journal January 2005
Telomere Shortening Occurs in Subsets of Normal Breast Epithelium as well as in Situ and Invasive Carcinoma journal March 2004
The erbB3 gene product is a receptor for heregulin. journal May 1994
Mammalian Telomeres End in a Large Duplex Loop journal May 1999
Identification of Human Rap1 journal May 2000
TRF2 Protects Human Telomeres from End-to-End Fusions journal February 1998
Switching and Signaling at the Telomere journal September 2001
Telomere repeat binding factors: keeping the ends in check journal May 2003
Cellular senescence, cancer and aging: the telomere connection journal November 2001
Tankyrase promotes telomere elongation in human cells journal October 2000
Evolving views of telomerase and cancer journal June 2003
Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma journal March 1999
Telomere Shortening Occurs Early During Breast Tumorigenesis: A Cause of Chromosome Destabilization Underlying Malignant Transformation? journal July 2004
Heregulin induces tyrosine phosphorylation of HER4/p180erbB4 journal December 1993
TIN2, a new regulator of telomere length in human cells journal December 1999
Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres journal July 2000
In situ analyses of genome instability in breast cancer journal August 2004
Protection of mammalian telomeres journal January 2002
Assessment of telomere length and factors that contribute to its stability journal February 2003
Telomere loss in cells treated with cisplatin journal April 1998
Ku Binds Telomeric DNA in Vitro journal July 1999
Reversible Manipulation of Telomerase Expression and Telomere Length journal August 2002
Adriamycin-induced Senescence in Breast Tumor Cells Involves Functional p53 and Telomere Dysfunction journal September 2002
Massive Telomere Loss Is an Early Event of DNA Damage-induced Apoptosis journal January 2003
The Human Rap1 Protein Complex and Modulation of Telomere Length journal April 2004
TIN2 Mediates Functions of TRF2 at Human Telomeres journal October 2004
Telosome, a Mammalian Telomere-associated Complex Formed by Multiple Telomeric Proteins journal September 2004
Rap1 Affects the Length and Heterogeneity of Human Telomeres journal December 2003
PARP1 Is a TRF2-associated Poly(ADP-Ribose)Polymerase and Protects Eroded Telomeres journal April 2006
Control of Human Telomere Length by TRF1 and TRF2 journal March 2000
Regulation of Telomere Length and Suppression of Genomic Instability in Human Somatic Cells by Ku86 journal June 2004
Role of Human Ku86 in Telomere Length Maintenance and Telomere Capping journal October 2004
Heregulins Implicated in Cellular Functions Other Than Receptor Activation journal January 2006

Cited By (1)

A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer journal June 2017

Figures / Tables (5)


Similar Records

Heregulin, a new interactor of the telosome/shelterin complex in human telomeres
Journal Article · Tue Jul 21 20:00:00 EDT 2015 · Oncotarget · OSTI ID:1627986

Related Subjects